SYNEOS HEALTH, INC.

SYNHUnited States

33 filed reports · 619 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$5.39B

FY2022 · to Dec 31, 2022

up +3.5% vs $5.21B

10-K

Net income

$266M

FY2022 · to Dec 31, 2022

up +13.5% vs $235M

10-K

Operating income

$403M

FY2022 · to Dec 31, 2022

up +3.6% vs $389M

10-K

Latest quarter

Revenue

$1.37B

Q2 FY2023 · to Jun 30, 2023

up +0.4% vs $1.36B

10-Q

Net income

$793K

Q2 FY2023 · to Jun 30, 2023

down −99.0% vs $77.7M

10-Q

Operating income

$42.2M

Q2 FY2023 · to Jun 30, 2023

down −63.8% vs $117M

10-Q

Filed reports

33 reports · Jun 2015 to Jun 2023

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR244,503Jun 2015 to Jun 2023
Annual · 10-KSEC EDGAR85,121Dec 2015 to Dec 2022
Quarterly · 10-Q/ASEC EDGAR1157Mar 2017

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q210-Q2023-06-302023-08-09319Open
FY2023 Q110-Q2023-03-312023-05-10228Open
FY202210-K2022-12-312023-02-161,095Open
FY2022 Q310-Q2022-09-302022-11-04249Open
FY2022 Q210-Q2022-06-302022-08-02168Open
FY2022 Q110-Q2022-03-312022-04-29166Open
FY202110-K2021-12-312022-02-17548Open
FY2021 Q310-Q2021-09-302021-11-03169Open
FY2021 Q210-Q2021-06-302021-08-09158Open
FY2021 Q110-Q2021-03-312021-04-29162Open
FY202010-K2020-12-312021-02-18551Open
FY2020 Q310-Q2020-09-302020-10-29172Open

Financial data

619 concepts · 9,781 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial592 concepts · 8,760 facts · Dec 2013 to Jun 2023

  • Net income loss50 · Dec 2013 to Jun 2023
  • Amortization of intangible assets48 · Dec 2013 to Jun 2023
  • Comprehensive income net of tax48 · Dec 2013 to Jun 2023
  • Costs and expenses48 · Dec 2013 to Jun 2023
  • Depreciation48 · Dec 2013 to Jun 2023
  • Income loss from continuing operations before income taxes extraordinary items noncontrolling interest48 · Dec 2013 to Jun 2023
  • Income tax expense benefit48 · Dec 2013 to Jun 2023
  • Interest expense (US GAAP)48 · Dec 2013 to Jun 2023
  • Nonoperating income expense48 · Dec 2013 to Jun 2023
  • Operating income loss48 · Dec 2013 to Jun 2023
  • Other nonoperating income expense48 · Dec 2013 to Jun 2023
  • Revenue48 · Dec 2013 to Jun 2023
  • Selling general and administrative expense48 · Dec 2013 to Jun 2023
  • Foreign currency transaction gain loss realized47 · Dec 2013 to Jun 2023
  • Foreign currency transaction gain loss unrealized47 · Dec 2013 to Jun 2023
  • Deferred income tax expense benefit46 · Dec 2013 to Jun 2023
  • Foreign currency transaction gain loss before tax46 · Dec 2013 to Jun 2023
  • Gains losses on extinguishment of debt46 · Dec 2013 to Dec 2022
  • Increase decrease in accounts payable and accrued liabilities46 · Dec 2013 to Jun 2023
  • Increase decrease in other operating capital net46 · Dec 2013 to Jun 2023
  • Net cash provided by used in financing activities46 · Dec 2013 to Jun 2023
  • Net cash provided by used in investing activities46 · Dec 2013 to Jun 2023
  • Net cash provided by used in operating activities46 · Dec 2013 to Jun 2023
  • Other noncash income expense46 · Dec 2013 to Jun 2023

Segment22 concepts · 653 facts · Dec 2013 to Jun 2023

  • Revenue132 · Dec 2013 to Jun 2023
  • Cost of goods and services sold (US GAAP)90 · Dec 2016 to Jun 2023
  • Operating income loss72 · Dec 2015 to Jun 2023
  • Selling general and administrative expense72 · Dec 2015 to Jun 2023
  • Goodwill foreign currency translation gain loss66 · Mar 2016 to Jun 2023
  • Cost of services56 · Dec 2013 to Mar 2018
  • Goodwill impairment loss49 · Dec 2014 to Jun 2023
  • Gross profit (US GAAP)42 · Dec 2013 to Jun 2017
  • Goodwill purchase accounting adjustments33 · Dec 2017 to Dec 2022
  • Goodwill, Translation Adjustments and Other12 · Dec 2014 to Dec 2018
  • Goodwill transfers6 · Mar 2021 to Dec 2022
  • Cost of reimbursable expense4 · Mar 2017 to Mar 2018
  • Goodwill acquired during period4 · Dec 2014 to Dec 2017
  • Asset impairment charges3 · Sep 2015 to Dec 2015
  • Goodwill translation adjustments3 · Sep 2015
  • Impairment of intangible assets finitelived2 · Jun 2014
  • Proceeds from sale of notes receivable2 · Dec 2020 to Jun 2021
  • Gain loss on sale of business1 · Dec 2020
  • Goodwill and intangible asset impairment1 · Mar 2015
  • Impairment of long lived assets held for use1 · Mar 2015
  • Noncash or part noncash divestiture amount of consideration received11 · Dec 2020
  • Proceeds from divestiture of businesses1 · Dec 2020

Geography3 concepts · 239 facts · Dec 2013 to Jun 2023

  • Revenue234 · Dec 2013 to Jun 2023
  • Concentration risk percentage14 · Jun 2015 to Sep 2016
  • Lessee, Operating Lease, Number of Existing Locations1 · Dec 2017

Product2 concepts · 129 facts · Dec 2016 to Dec 2019

  • Revenue87 · Dec 2016 to Dec 2019
  • Cost of goods and services sold (US GAAP)42 · Dec 2016 to Dec 2019

Segments

1,021 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments5 members · 653 facts

  • Clinical Solutions254 · Dec 2015 to Jun 2023
  • Commercial Solutions234 · Dec 2015 to Jun 2023
  • Phase I Services76 · Dec 2013 to Jun 2017
  • Clinical Development Services68 · Dec 2013 to Jun 2017
  • Global Consulting21 · Mar 2014 to Sep 2015

Statement geographicalsrt:StatementGeographicalAxis5 members · 135 facts

  • Asia-Pacific27 · Mar 2018 to Jun 2023
  • Europe, Middle East and Africa27 · Mar 2018 to Jun 2023
  • Latin America27 · Mar 2018 to Jun 2023
  • North America27 · Mar 2018 to Jun 2023
  • United States27 · Mar 2018 to Jun 2023

Product or service2 members · 129 facts

  • Service revenue99 · Dec 2016 to Dec 2019
  • Reimbursable out-of-pocket expenses30 · Dec 2016 to Dec 2019

Statement geographicalus-gaap:StatementGeographicalAxis6 members · 104 facts

  • Latin America22 · Dec 2013 to Mar 2018
  • United States21 · Dec 2013 to Mar 2018
  • Asia-Pacific20 · Dec 2013 to Mar 2018
  • Europe, Middle East and Africa20 · Dec 2013 to Mar 2018
  • North America20 · Dec 2013 to Mar 2018
  • Raleigh, North Carolina1 · Dec 2017

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of SYNEOS HEALTH, INC. (SYNH) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.

SYNEOS HEALTH, INC. (SYNH): FY2022 revenue $5.39B · FactIQ